MIRXES-B (02629) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Results and Discuss Final Dividend

Bulletin Express03-19

Mirxes Holding Company Limited (stock code: 02629, abbreviated as “MIRXES-B”) announced that its board of directors will convene on Tuesday, 31 March 2026.

Key agenda items include: 1. Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025. 2. Authorising the publication of the FY2025 results. 3. Considering a recommendation for a final dividend, if any. 4. Addressing other routine business matters.

Board composition as of the announcement date (19 March 2026) comprises: • Executive Directors: Dr. ZHOU Lihan (also Chief Executive Officer) and Dr. ZOU Ruiyang. • Non-executive Directors: Dr. TOO Heng Phon, Dr. LE Beilin and Mr. LIU Da. • Independent Non-executive Directors: Dr. LAM Sin Lai Judy, Mr. FANG Xiao and Ms. MA Andrea Lo Ling.

The meeting outcome will shape MIRXES-B’s disclosure schedule for its FY2025 performance and signal potential shareholder returns via a final dividend proposal.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment